MAY_capital

среднесрочная идея в лонг VRPX

NASDAQ:VRPX   Virpax Pharmaceuticals, Inc.
разработчик препаратов, в т.ч. назальных от COVID
идея: в среднесрок
вблизи 4,0-3,9
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.